Frontlight ResearchEarly access
Trial site
M Health Fairview St. John's Hospital
- 10running trials
- 2closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Stroke4 trials
- Atrial fibrillation2 trials
- Lung cancer2 trials
- Aortic stenosis1 trial
- Bladder cancer1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Heart failure1 trial
- Obesity1 trial
- Ovarian cancer1 trial
- and 2 more
- Phase
- Phase 37 trials
- Phase 21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Recruiting3 trials
- Completed2 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Boston Scientific Corporation2 trials
- Eli Lilly and Company2 trials
- Joseph Broderick, MD2 trials
- Pfizer2 trials
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Active, not recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aortic stenosis1 recruiting
- Cervical cancer1 recruiting
- Lung cancer1 recruiting
- Stroke1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026